SCHEMBL32665031

SCHEMBL32665031

O=C(c1ccc(F)c(OS(=O)(=O)F)c1)N1CCC2(CC1)CC(N1C(=O)C=CC1=O)C2

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 8/20 0.38
CYP3A4 P08684 3/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPK1 P28482 1/20 0.36
CYP2D6 P10635 2/20 0.36
USP2 O75604 2/20 0.36
CYP1A2 P05177 2/20 0.36
HIF1A Q16665 1/20 0.36
ADRA1A P35348 2/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
DRD2 P14416 1/20 0.35
NPBWR1 P48145 1/20 0.34
MCHR1 Q99705 1/20 0.34
MGLL Q99685 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665176 0.92 STS (0.36) HTR1ACYP3A4ALDH1A1KDM4EHPGD
SCHEMBL32665523 0.85 CYP2D6 (0.41) CYP3A4ALDH1A1HPGDTSHRHSD17B10
SCHEMBL32665186 0.83 MAPK1 (0.41) CYP3A4ALDH1A1HPGDTSHRHSD17B10
SCHEMBL32665432 0.79 NPSR1 (0.36) ALDH1A1MEN1KMT2ADRD2
SCHEMBL32665089 0.73 DOCK5 (0.35) ALDH1A1MAPK1
SCHEMBL32665268 0.69 CYP2C9 (0.33) CYP3A4ALDH1A1TSHRHSD17B10MAPK1
SCHEMBL32665454 0.69 FFAR4 (0.38) HTR1ACYP3A4ALDH1A1HPGDTSHR
SCHEMBL32665034 0.69 L3MBTL3 (0.46) ALDH1A1KDM4EMEN1KMT2AMGLL
SCHEMBL2762664 0.66 MAPK1 (0.62) HTR1ACYP3A4ALDH1A1KDM4EHPGD
Hydrochloric Acid SCHEMBL2763425 0.66 MAPK1 (0.60) HTR1ACYP3A4ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A HTR1A 4144/4885CYP3A4 4706/4885ALDH1A1 3714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.